Sharklet Technologies, Inc., a biotechnology company lauded for the creation and
commercialization of Sharklet®, the world’s first micro-texture that inhibits bacterial growth on surfaces,
today announced that it has completed a financing event led by Peaceful Union, an equity medical
device firm in Hangzhou, China. Terms of the transaction were not disclosed.
The acquisition of the company will enable Sharklet Technologies to accelerate the development of
Sharklet for medical devices where chemical-free bacterial inhibition is desired as well as high-touch
surfaces prone to bacterial contamination. The company also will accelerate development of a newly
enhanced wound dressing technology to encourage healing.